We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Clinical Guidelines Synopsis |

Use of HPV Vaccine in Males and Females

Adam S. Cifu, MD1; Andrew M. Davis, MD, MPH2
[+] Author Affiliations
1Department of Medicine, University of Chicago
2Section of General Internal Medicine, University of Chicago, Chicago, Illinois
JAMA. 2014;312(18):1920-1921. doi:10.1001/jama.2014.12274.
Text Size: A A A
Published online


Box Section Ref ID

Guideline title Human Papillomavirus (HPV) ACIP Vaccine Recommendations

Developer Advisory Committee for Immunization Practices (ACIP)

Release date August 29, 2014

Prior version May 28, 2010

Funding source US Department of Health and Human Services (DHHS)

Target population Girls and women aged 11-26 years; boys and men aged 11-21 years

Major Recommendations

  • HPV vaccination (either bivalent or quadrivalent) should be administered to girls aged 11-12 years.

  • Girls and women aged 13-26 years who have not started or completed the vaccine series should be vaccinated.

  • Quadrivalent HPV vaccination should be administered to boys aged 11 or 12 years.

  • Boys and men aged 13-21 years who have not been vaccinated previously or who have not completed the 3-dose series should also receive the quadrivalent vaccine. Males aged 22-26 years may be vaccinated.

  • Either vaccine can be administered to those as young as 9 years of age.

  • Quadrivalent HPV vaccination is also recommended for men who have sex with men and immunocompromised persons up to 26 years.

  • The vaccine is administered in a 3-dose schedule. The second dose should be administered 1 to 2 months after the first dose and the third dose should be administered 6 months after the first dose.

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

4 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles